We at Insider Monkey have gone over 700 13F filings that hedge funds and prominent investors are required to file by the government. The 13F filings show the funds’ and investors’ portfolio positions as of September 30. In this article we look at what those investors think of Marine Products Corp. (NYSE:MPX).
Is Marine Products Corp. the right investment to pursue these days? Prominent investors are becoming more confident. The number of long hedge fund positions went up by 2 in recent months. MPX was in 4 hedge funds’ portfolios at the end of the third quarter of 2015. There were 2 hedge funds in our database with MPX holdings at the end of the previous quarter. At the end of this article we will also compare MPX to other stocks including Model N Inc (NYSE:MODN), Orexigen Therapeutics, Inc. (NASDAQ:OREX), and Tandem Diabetes Care Inc (NASDAQ:TNDM) to get a better sense of its popularity.
In the financial world there are a lot of methods that stock traders employ to assess their holdings. A duo of the less known methods are hedge fund and insider trading signals. We have shown that, historically, those who follow the best picks of the top investment managers can outperform the broader indices by a very impressive amount (see the details here).
With all of this in mind, let’s check out the fresh action surrounding Marine Products Corp. (NYSE:MPX).
What does the smart money think about Marine Products Corp. (NYSE:MPX)?
At the end of the third quarter, a total of 4 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of 100% from one quarter earlier. With hedge funds’ capital changing hands, there exists a select group of key hedge fund managers who were boosting their stakes significantly (or already accumulated large positions).
According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Mario Gabelli’s GAMCO Investors has the number one position in Marine Products Corp. (NYSE:MPX), worth close to $16.1 million, comprising 0.1% of its total 13F portfolio. The second most bullish fund manager is Renaissance Technologies, holding a $0.3 million position; less than 0.1%% of its 13F portfolio is allocated to the stock. Other peers with similar optimism consist of Mark Coe’s Coe Capital Management and Gavin Saitowitz and Cisco J. del Valle’s Springbok Capital.